Bank of New York Mellon’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-19,220
| Closed | -$8.07K | – | 4494 |
|
|
2022
Q4 | $8.07K | Sell |
19,220
-16,300
| -46% | -$8.76K | ﹤0.01% | 4432 |
|
|
2022
Q3 | $28K | Sell |
35,520
-295
| -0.8% | -$310 | ﹤0.01% | 4408 |
|
|
2022
Q2 | $45K | Sell |
35,815
-121,045
| -77% | -$159K | ﹤0.01% | 4371 |
|
|
2022
Q1 | $221K | Sell |
156,860
-11,702
| -7% | -$25K | ﹤0.01% | 4188 |
|
|
2021
Q4 | $458K | Sell |
168,562
-193,041
| -53% | -$711K | ﹤0.01% | 3864 |
|
|
2021
Q3 | $1.72M | Buy |
361,603
+10,723
| +3% | +$78.3K | ﹤0.01% | 3078 |
|
|
2021
Q2 | $2.83M | Sell |
350,880
-15,335
| -4% | -$128K | ﹤0.01% | 2785 |
|
|
2021
Q1 | $2.94M | Buy |
366,215
+5,872
| +2% | +$54.7K | ﹤0.01% | 2703 |
|
|
2020
Q4 | $3.23M | Sell |
360,343
-21,893
| -6% | -$182K | ﹤0.01% | 2567 |
|
|
2020
Q3 | $2.87M | Sell |
382,236
-4,203
| -1% | -$29.1K | ﹤0.01% | 2476 |
|
|
2020
Q2 | $2.46M | Sell |
386,439
-21,186
| -5% | -$142K | ﹤0.01% | 2555 |
|
|
2020
Q1 | $3.03M | Sell |
407,625
-27,583
| -6% | -$214K | ﹤0.01% | 2324 |
|
|
2019
Q4 | $3.93M | Sell |
435,208
-19,845
| -4% | -$167K | ﹤0.01% | 2451 |
|
|
2019
Q3 | $3.41M | Sell |
455,053
-1,650
| -0.4% | -$9.26K | ﹤0.01% | 2466 |
|
|
2019
Q2 | $2.37M | Sell |
456,703
-29,283
| -6% | -$191K | ﹤0.01% | 2718 |
|
|
2019
Q1 | $4.07M | Buy |
485,986
+20,747
| +4% | +$149K | ﹤0.01% | 2435 |
|
|
2018
Q4 | $2M | Buy |
465,239
+33,222
| +8% | +$294K | ﹤0.01% | 2724 |
|
|
2018
Q3 | $6.29M | Buy |
432,017
+16,023
| +4% | +$266K | ﹤0.01% | 2291 |
|
|
2018
Q2 | $7.74M | Sell |
415,994
-2,600
| -0.6% | -$47K | ﹤0.01% | 2163 |
|
|
2018
Q1 | $7.28M | Buy |
418,594
+1,112
| +0.3% | +$19.6K | ﹤0.01% | 2154 |
|
|
2017
Q4 | $7.04M | Sell |
417,482
-6,235
| -1% | -$101K | ﹤0.01% | 2184 |
|
|
2017
Q3 | $6.67M | Buy |
423,717
+15,995
| +4% | +$228K | ﹤0.01% | 2196 |
|
|
2017
Q2 | $5.38M | Buy |
407,722
+25,698
| +7% | +$338K | ﹤0.01% | 2297 |
|
|
2017
Q1 | $4.55M | Sell |
382,024
-11,464
| -3% | -$137K | ﹤0.01% | 2378 |
|
|
2016
Q4 | $5.13M | Buy |
393,488
+52,046
| +15% | +$599K | ﹤0.01% | 2296 |
|
|
2016
Q3 | $3.81M | Buy |
341,442
+14,524
| +4% | +$175K | ﹤0.01% | 2373 |
|
|
2016
Q2 | $3.96M | Sell |
326,918
-485,063
| -60% | -$5.72M | ﹤0.01% | 2328 |
|
|
2016
Q1 | $10.7M | Buy |
811,981
+20,622
| +3% | +$292K | ﹤0.01% | 1801 |
|
|
2015
Q4 | $13.8M | Sell |
791,359
-41,861
| -5% | -$756K | ﹤0.01% | 1643 |
|
|
2015
Q3 | $12.1M | Buy |
833,220
+159,695
| +24% | +$2.79M | ﹤0.01% | 1749 |
|
|
2015
Q2 | $14.6M | Buy |
673,525
+370,807
| +122% | +$7.85M | ﹤0.01% | 1720 |
|
|
2015
Q1 | $5.88M | Buy |
302,718
+6,254
| +2% | +$108K | ﹤0.01% | 2223 |
|
|
2014
Q4 | $4.97M | Sell |
296,464
-7,178
| -2% | -$109K | ﹤0.01% | 2319 |
|
|
2014
Q3 | $3.59M | Sell |
303,642
-20,081
| -6% | -$306K | ﹤0.01% | 2507 |
|
|
2014
Q2 | $5.95M | Sell |
323,723
-4,592
| -1% | -$78K | ﹤0.01% | 2229 |
|
|
2014
Q1 | $6.26M | Buy |
328,315
+8,925
| +3% | +$184K | ﹤0.01% | 2188 |
|
|
2013
Q4 | $7.41M | Sell |
319,390
-20,641
| -6% | -$427K | ﹤0.01% | 2053 |
|
|
2013
Q3 | $5.87M | Buy |
340,031
+34,606
| +11% | +$550K | ﹤0.01% | 2146 |
|
|
2013
Q2 | $4.38M | Buy |
+305,425
| New | +$4.23M | ﹤0.01% | 2264 |
|
Other funds holding IVC
PCMI
IIM
AA
WFA
HNB
HCM
Bank of New York Mellon's IVC Position: Q1 2023 in Review
Bank of New York Mellon sold out of Invacare Corporation (IVC) in Q1 2023, closing a stake of 19,220 shares — an estimated $8.07K sold.
Bank of New York Mellon first reported a position in IVC in Q2 2013 and held it in 39 quarters. The position peaked at $14.6M in Q2 2015. 10 funds tracked by Wall St. Rank hold IVC as of Q1 2023.
- Bank of New York Mellon reported no remaining Invacare Corporation position as of Q1 2023 after selling out during the quarter.
- Bank of New York Mellon sold 19,220 Invacare Corporation shares in Q1 2023, an estimated $8.07K.
- Bank of New York Mellon first reported a position in Invacare Corporation in Q2 2013 and held it in 39 quarters.
- Bank of New York Mellon's Invacare Corporation position peaked at $14.6M in Q2 2015.
- 10 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2023.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.